PLA2G7 and myeloid sarcoma: The results of the logistic regression analysis for determining MS, which included both biomarkers adjusted for age and gender, were as follows: odds ratio (OR) for LpPLA2: 1.02 (confidence interval [CI]: 1.00–1.02, P = 0.03) and OR for hsCRP: 2.5 (CI: 1.65–3.80, P < 0.0001).